Analyst Ratings for Kempharm (KMPH)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/17/2022 | Cantor Fitzgerald | Louis Chen | New Coverage | Overweight (N/A) |
20.00 (N/A) |
4.39 (5.81) |
32.35% | Details |
| 9/15/2022 | Canaccord Genuity » Updated 11/10/2022 |
Sumant Kulkarni | New Coverage | Buy (N/A) |
19.00 (20.00) |
6.08 (5.81) |
-4.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
